AI Terminal
Chemring Group PLC
Transaction in Own Shares • Aug 25, 2023
5264_rns_2023-08-25_2c239414-0dff-4850-b348-de86f1eb09fa.html
Transaction in Own Shares
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 3904K
Chemring Group PLC
25 August 2023
25th August 2023
Chemring Group PLC
("Chemring" or the "Company")
Transaction in Own Shares
Chemring Group PLC ("Chemring" or the "Company") announces it has purchased the following number of its ordinary shares of 1 pence each through Investec Bank plc.
Ordinary Shares
| Date of purchase: | 24th August 2023 |
| Number of ordinary shares purchased: | 10,504 |
| Lowest price per share (pence): | 284 |
| Highest price per share (pence): | 286.5 |
| Weighted average price per day (pence): | 285.2932 |
The Company intends to cancel the purchased shares.
The table below contains detailed information about the purchases made as part of the buyback programme which was announced by the Company on 1 August 2023 (the "Programme").
Aggregate information:
| Venue | Volume-weighted average price (p) | Aggregated volume | Lowest price per share (p) | Highest price per share (p) |
| XLON | 285.2932 | 10,504 | 284.00 | 286.50 |
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Investec on behalf of the Company as part of the Programme is detailed below:
| Date and time of each trade | Number of shares purchased | Price (pence per share) | Trading Venue | Transaction Reference Number |
| 24 August 2023 08:09:55 | 293 | 284.00 | XLON | 00229219566TRLO1 |
| 24 August 2023 08:09:55 | 80 | 284.00 | XLON | 00229219565TRLO1 |
| 24 August 2023 08:28:53 | 186 | 286.50 | XLON | 00229224703TRLO1 |
| 24 August 2023 08:28:53 | 575 | 286.50 | XLON | 00229224702TRLO1 |
| 24 August 2023 08:48:56 | 330 | 286.50 | XLON | 00229230493TRLO1 |
| 24 August 2023 09:07:07 | 285 | 286.50 | XLON | 00229236304TRLO1 |
| 24 August 2023 09:22:44 | 340 | 285.50 | XLON | 00229242170TRLO1 |
| 24 August 2023 09:22:46 | 350 | 285.50 | XLON | 00229242183TRLO1 |
| 24 August 2023 11:18:52 | 735 | 285.50 | XLON | 00229290518TRLO1 |
| 24 August 2023 11:59:51 | 151 | 286.00 | XLON | 00229291496TRLO1 |
| 24 August 2023 12:22:24 | 211 | 286.00 | XLON | 00229291842TRLO1 |
| 24 August 2023 12:36:31 | 341 | 285.50 | XLON | 00229292186TRLO1 |
| 24 August 2023 13:01:27 | 366 | 285.00 | XLON | 00229292535TRLO1 |
| 24 August 2023 14:20:44 | 101 | 284.50 | XLON | 00229294030TRLO1 |
| 24 August 2023 14:31:34 | 363 | 284.00 | XLON | 00229294317TRLO1 |
| 24 August 2023 14:55:34 | 372 | 284.50 | XLON | 00229295039TRLO1 |
| 24 August 2023 15:18:30 | 753 | 285.50 | XLON | 00229295778TRLO1 |
| 24 August 2023 15:18:30 | 254 | 285.50 | XLON | 00229295777TRLO1 |
| 24 August 2023 15:18:30 | 480 | 285.50 | XLON | 00229295776TRLO1 |
| 24 August 2023 15:32:18 | 700 | 285.00 | XLON | 00229296270TRLO1 |
| 24 August 2023 16:03:21 | 358 | 285.00 | XLON | 00229297626TRLO1 |
| 24 August 2023 16:03:21 | 358 | 285.00 | XLON | 00229297625TRLO1 |
| 24 August 2023 16:03:21 | 359 | 285.00 | XLON | 00229297624TRLO1 |
| 24 August 2023 16:04:04 | 149 | 285.00 | XLON | 00229297663TRLO1 |
| 24 August 2023 16:06:09 | 149 | 285.00 | XLON | 00229297750TRLO1 |
| 24 August 2023 16:06:09 | 159 | 285.00 | XLON | 00229297749TRLO1 |
| 24 August 2023 16:06:09 | 199 | 285.00 | XLON | 00229297748TRLO1 |
| 24 August 2023 16:06:09 | 342 | 285.00 | XLON | 00229297747TRLO1 |
| 24 August 2023 16:06:09 | 209 | 285.00 | XLON | 00229297746TRLO1 |
| 24 August 2023 16:19:59 | 956 | 285.00 | XLON | 00229298313TRLO1 |
For further information:
| Rupert Pittman | Group Director of Corporate Affairs, Chemring Group PLC | +44 (0) 1794 463401 |
| James McFarlane | MHP Communications | +44 (0) 20 3128 8100 |
| Ollie Hoare |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSSESFMLEDSESA